INZY - Inozyme Pharma Inc
4
0.010 0.250%
Share volume: 1,459,443
Last Updated: 06-30-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$3.99
0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-05-2024 | 03-10-2025 | 05-14-2025 | |
| Assets | ||||||
| Total Assets | 176.943 M | 155.712 M | 143.361 M | 123.182 M | 95.164 M | |
| Current Assets | 174.324 M | 152.962 M | 140.937 M | 120.676 M | 93.637 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 145.535 M | 129.290 M | 107.033 M | 92.006 M | 58.930 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 20.618 M | 15.233 M | 24.575 M | 21.081 M | 25.846 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.316 M | 1.128 M | 945.000 K | 784.000 K | 608.000 K | |
| Other Assets | 1.303 M | 1.622 M | 1.479 M | 1.722 M | 919.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 176.943 M | 155.712 M | 143.361 M | 123.182 M | 95.164 M | |
| Total liabilities | 58.107 M | 61.292 M | 60.573 M | 65.356 M | 63.366 M | |
| Total current liabilities | 12.406 M | 15.541 M | 18.344 M | 33.898 M | 42.781 M | |
| Accounts Payable | 2.166 M | 3.527 M | 2.210 M | 2.530 M | 3.670 M | |
| Other liabilities | 669.000 K | 419.000 K | 164.000 K | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 45.032 M | 45.332 M | 42.065 M | 31.458 M | 20.585 M | |
| Other liabilities | 669.000 K | 419.000 K | 164.000 K | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 118.836 M | 94.420 M | 82.788 M | 57.826 M | 31.798 M | |
| Common stock | 428.218 M | 430.833 M | 443.482 M | 445.711 M | 447.796 M | |
| Retained earnings | -309.277 M | -336.310 M | -360.880 M | -387.954 M | -415.993 M |